Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?
Purpose. To determine if there is sufficient evidence to recommend the addition of pentoxifylline to standard ACE inhibitor and ARB therapy in chronic kidney disease patients to reduce proteinuria and preserve kidney function. Methods: A search of the literature was conducted using the PubMed.gov a...
Saved in:
Main Authors: | Cody Carson (Author), Akram Al-Makki (Author), Brian Shepler (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
by: Geert Byttebier, et al.
Published: (2021) -
Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?
by: Christian A Devaux
Published: (2020) -
Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
by: Elena Raccuglia, et al.
Published: (2009) -
Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease
by: Tiffany Lin, et al.
Published: (2022) -
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials
by: Jaclyn Gruver, et al.
Published: (2023)